AURKA, BIRC5 and PLK1 as potential biomarkers of response in radiation-resistant colorectal cancer

dc.centroFacultad de Medicinaes_ES
dc.contributor.authorBurgos-Molina, Antonio Manuel
dc.contributor.authorRodríguez-García, M.
dc.contributor.authorGonzález-Vidal, A.
dc.contributor.authorMercado-Sáenz, Silvia
dc.contributor.authorRuiz-Gómez, Miguel José
dc.date.accessioned2025-01-08T10:17:23Z
dc.date.available2025-01-08T10:17:23Z
dc.date.issued2024-11
dc.departamentoEspecialidades Quirúrgicas, Bioquímica e Inmunología
dc.description.abstractThe study demonstrated that AURKA, BIRC5 and PLK1 proteins are hyper-expressed in patients affected by colon and rectum adenocarcinoma resistant to radiotherapy. The validation of the expression levels in patient samples shows that they are conserved in tumor stages I-IV, suggesting their potential as possible biomarkers.es_ES
dc.identifier.urihttps://hdl.handle.net/10630/35955
dc.language.isoenges_ES
dc.publisherASEICAes_ES
dc.relation.eventdate13-15 Nov. 2024.es_ES
dc.relation.eventplaceZaragozaes_ES
dc.relation.eventtitle19th ASEICA INTERNATIONAL CONGRESSes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCáncer colorrectales_ES
dc.subjectInmunidades_ES
dc.subject.otherImmune systemes_ES
dc.titleAURKA, BIRC5 and PLK1 as potential biomarkers of response in radiation-resistant colorectal canceres_ES
dc.typeconference outputes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationde49c054-e443-41f5-94e9-bd9c022959e9
relation.isAuthorOfPublication4e758ad1-1943-4e81-a3cb-efe226079e39
relation.isAuthorOfPublication52572afd-4d3c-4c34-82a7-3774888d42e1
relation.isAuthorOfPublication.latestForDiscoveryde49c054-e443-41f5-94e9-bd9c022959e9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
9- RR gene expression.pdf
Size:
110.72 KB
Format:
Adobe Portable Document Format
Description: